Article Text
Abstract
Although informed consent models for prescribing hormone replacement therapy are becoming increasingly prevalent, many physicians continue to require an assessment and referral letter from a mental health professional prior to prescription. Drawing on personal and communal experience, the author argues that assessment and referral requirements are dehumanising and unethical, foregrounding the ways in which these requirements evidence a mistrust of trans people, suppress the diversity of their experiences and sustain an unjustified double standard in contrast to other forms of clinical care. Physicians should abandon this unethical requirement in favour of an informed consent approach to transgender care.
- clinical ethics
- minorities
- sexuality/gender
- feminism
Statistics from Altmetric.com
Footnotes
Contributors FA is the sole contributor.
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.
Other content recommended for you
- Integrity and rights to gender-affirming healthcare
- Responding to objections to gatekeeping for hormone replacement therapy
- Reply to ‘Hormone replacement therapy: informed consent without assessment?’
- Detransition needs further understanding, not controversy
- Hormone replacement therapy: informed consent without assessment?
- Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
- Gender dysphoria in young people is rising—and so is professional disagreement
- Gender identity and sexual orientation: a glossary
- Validity and reliability of the Thai version of the Utrecht Gender Dysphoria Scale-Gender Spectrum (UGDS-GS) in Thai youths and young adults with gender dysphoria
- Exploring gender dysphoria and related outcomes in a prospective cohort study: protocol for the Swedish Gender Dysphoria Study (SKDS)